207 related articles for article (PubMed ID: 19922476)
21. The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification.
Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
Curr Opin Cardiol; 2010 Jul; 25(4):394-8. PubMed ID: 20549844
[TBL] [Abstract][Full Text] [Related]
22. Carotid intima-media thickness: knowledge and application to everyday practice.
Cobble M; Bale B
Postgrad Med; 2010 Jan; 122(1):10-8. PubMed ID: 20107284
[TBL] [Abstract][Full Text] [Related]
23. Effect of folic acid supplementation on the progression of carotid intima-media thickness: a meta-analysis of randomized controlled trials.
Qin X; Xu M; Zhang Y; Li J; Xu X; Wang X; Xu X; Huo Y
Atherosclerosis; 2012 Jun; 222(2):307-13. PubMed ID: 22209480
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
25. Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients.
Willey KA; Kidd JF; Harris JP; Xu ZR; Yue DK
Diabetes Care; 1995 Nov; 18(11):1502-3. PubMed ID: 8722078
[No Abstract] [Full Text] [Related]
26. Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Shimada N; Ebihara I; Koide H
Kidney Blood Press Res; 2004; 27(2):121-6. PubMed ID: 15051932
[TBL] [Abstract][Full Text] [Related]
27. Improving cardiovascular risk--applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes.
Fisher M
Int J Clin Pract; 2009 Sep; 63(9):1354-68. PubMed ID: 19691621
[TBL] [Abstract][Full Text] [Related]
28. The role of lipid-lowering treatment in carotid intima-media thickness.
Kotsis V
Am J Hypertens; 2006 Jun; 19(6):654-5. PubMed ID: 16733241
[No Abstract] [Full Text] [Related]
29. Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
Kodama M; Yamasaki Y; Sakamoto K; Yoshioka R; Matsuhisa M; Kajimoto Y; Kosugi K; Ueda N; Hori M
Thromb Res; 2000 Feb; 97(4):239-45. PubMed ID: 10674411
[TBL] [Abstract][Full Text] [Related]
30. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
[TBL] [Abstract][Full Text] [Related]
31. Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness.
Vigili de Kreutzenberg S; Tiengo A; Avogaro A
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):667-73. PubMed ID: 19500958
[TBL] [Abstract][Full Text] [Related]
32. Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial.
Magalhães JP; Melo X; Correia IR; Ribeiro RT; Raposo J; Dores H; Bicho M; Sardinha LB
Cardiovasc Diabetol; 2019 Mar; 18(1):34. PubMed ID: 30885194
[TBL] [Abstract][Full Text] [Related]
33. Effect of antihypertensive therapy on progression of carotid intima-media thickness in patients with type 2 diabetes mellitus.
Zheng L; Hodis HN; Buchanan TA; Li Y; Mack WJ
Am J Cardiol; 2007 Apr; 99(7):956-60. PubMed ID: 17398191
[TBL] [Abstract][Full Text] [Related]
34. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis.
Tyrrell PN; Beyene J; Feldman BM; McCrindle BW; Silverman ED; Bradley TJ
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):1014-26. PubMed ID: 20150560
[TBL] [Abstract][Full Text] [Related]
35. Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.
Beishuizen ED; van de Ree MA; Jukema JW; Tamsma JT; van der Vijver JC; Meinders AE; Putter H; Huisman MV
Diabetes Care; 2004 Dec; 27(12):2887-92. PubMed ID: 15562202
[TBL] [Abstract][Full Text] [Related]
36. Effect of rimonabant on carotid intima-media thickness (CIMT) progression in patients with abdominal obesity and metabolic syndrome: the AUDITOR Trial.
O'Leary DH; Reuwer AQ; Nissen SE; Després JP; Deanfield JE; Brown MW; Zhou R; Zabbatino SM; Job B; Kastelein JJ; Visseren FL;
Heart; 2011 Jul; 97(14):1143-50. PubMed ID: 21610270
[TBL] [Abstract][Full Text] [Related]
37. Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.
Langenfeld MR; Forst T; Hohberg C; Kann P; Lübben G; Konrad T; Füllert SD; Sachara C; Pfützner A
Circulation; 2005 May; 111(19):2525-31. PubMed ID: 15883215
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, placebo-controlled trial of spironolactone on carotid intima-media thickness in nondiabetic hemodialysis patients.
Vukusich A; Kunstmann S; Varela C; Gainza D; Bravo S; Sepulveda D; Cavada G; Michea L; Marusic ET
Clin J Am Soc Nephrol; 2010 Aug; 5(8):1380-7. PubMed ID: 20522535
[TBL] [Abstract][Full Text] [Related]
39. Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.
Hernandez AV; Usmani A; Rajamanickam A; Moheet A
Am J Cardiovasc Drugs; 2011; 11(2):115-28. PubMed ID: 21294599
[TBL] [Abstract][Full Text] [Related]
40. Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetes.
Djaberi R; Schuijf JD; Jukema JW; Rabelink TJ; Stokkel MP; Smit JW; de Koning EJ; Bax JJ
Diabetes Care; 2010 Feb; 33(2):372-4. PubMed ID: 19918012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
